Therapeutic use Tuberculosis: administer pyridoxine to prevent INH-induced peripheral neuropathy Hyperemesis gravidarum Characteristics Synonyms: biotin Inactive precursor (provitamin): none Active form: biotin Sources Plants (e.g., soy products, nuts), animal products (e.g., liver, egg yolk, dairy products) Small amounts are synthesized by intestinal flora Resorption: pancreatic enzyme biotinidase cleaves protein-bound biotin into free biotin active intestinal resorption Transport in blood: mainly free Functions Coenzyme for various carboxylase enzyme complexes, which all add a 1-carbon group Fatty acid synthesis: acetyl-CoA carboxylase Acetyl-CoA (2C) malonyl-CoA (3C) Gluconeogenesis: pyruvate carboxylase Pyruvate (3C) oxaloacetate (4C) Fatty acid reduction: propionyl-CoA carboxylase Propionyl-CoA (3C) methylmalonyl-CoA (4C) Biotin is a coenzyme in all carboxylase enzyme complexes that are not vitamin K-dependent
History of keloids, hypertrophic scarring, or abnormal wound healing excluded from the wound-healing trial (NCT07437586)
Direct Preventive Care offers a range of GLP-1 medications to help manage weight and improve metabolic health
It is also listed on the PBS for patients who fulfill the following key clinical criteria: an eGFR of 25 mL/min/1.73 m 2 or greater an ACR of 22.6 mg/mmol or greater must be on a stable dose of either an ACE inhibitor or ARB must not have established heart failure with reduced ejection fraction must be on an SGLT-2 inhibitor unless medically contraindicated or intolerant (please refer to the full PBS clinical criteria at: Combination therapy Some evidence suggests that combination therapy with SGLT-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and CKD reduces the risk of CV events and the mineralocorticoid receptor antagonist-associated risk of hyperkalaemia without a significant interaction between the two drugs
Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this article and any liability therefore (including in respect of direct, indirect, or consequential loss or damage) is expressly disclaimed
